KSV01 Injection

DRUG2 trials

Sponsors

Zhejiang University, TCRx Therapeutics Co.Ltd

Conditions

B-ALLDiffuse Large B Cell Lymphoma (DLBCL)Non-Hodgkin Lymphoma

Phase 1

KSV01 Injection as the Therapy for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

RecruitingNCT07246707

Zhejiang UniversityB-ALL

Start: 2026-01-02End: 2028-06-01Target: 30Updated: 2026-07-17

KSV01 Injection for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

RecruitingNCT07260812

TCRx Therapeutics Co.LtdDiffuse Large B Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma

Start: 2025-09-01End: 2028-12-31Target: 18Updated: 2026-04-13